- Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infantsJ H Rodman
Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Infect Dis 180:1844-50. 1999..Studies of simpler oral regimens of zidovudine can now be evaluated regarding the ability to achieve these pharmacologic end points associated with highly effective parenteral therapy...
- Design of antiretroviral clinical trials for HIV-1 infected pregnant women and their newborn infantsJ H Rodman
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Semin Perinatol 25:170-6. 2001....
- Pharmacokinetics of oral zidovudine administered during labour: a preliminary studyM Mirochnick
Department of Pediatrics, Boston University School of Medicine, Boston, MA 02118, and Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN, USA
HIV Med 8:451-6. 2007....
- Single-dose pharmacokinetics and safety of the oral antiviral compound adefovir dipivoxil in children infected with human immunodeficiency virus type 1. The Pediatrics AIDS Clinical Trials GroupW T Hughes
St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Antimicrob Agents Chemother 44:1041-6. 2000..07) among the subjects in the older and younger age groups. No significant adverse events were encountered. These data provide the basis for a multidose phase II study of adefovir dipivoxil in HIV-infected infants and children...